digital therapeutics ltd
digital therapeutics ltd Company Information
Company Number
09851330
Next Accounts
Sep 2025
Industry
Other human health activities
Shareholders
digital therapeutics inc.
Group Structure
View All
Contact
Registered Address
ps.03, third floor, peer house, ps.03, third floor, peer house, holborn, london, WC1X 8LZ
Website
quitgenius.comdigital therapeutics ltd Estimated Valuation
Pomanda estimates the enterprise value of DIGITAL THERAPEUTICS LTD at £727.9k based on a Turnover of £1.3m and 0.56x industry multiple (adjusted for size and gross margin).
digital therapeutics ltd Estimated Valuation
Pomanda estimates the enterprise value of DIGITAL THERAPEUTICS LTD at £0 based on an EBITDA of £-5m and a 4.42x industry multiple (adjusted for size and gross margin).
digital therapeutics ltd Estimated Valuation
Pomanda estimates the enterprise value of DIGITAL THERAPEUTICS LTD at £0 based on Net Assets of £-15.1m and 2.47x industry multiple (adjusted for liquidity).
Edit your figures and get a professional valuation report.
Digital Therapeutics Ltd Overview
Digital Therapeutics Ltd is a live company located in holborn, WC1X 8LZ with a Companies House number of 09851330. It operates in the other human health activities sector, SIC Code 86900. Founded in November 2015, it's largest shareholder is digital therapeutics inc. with a 100% stake. Digital Therapeutics Ltd is a young, small sized company, Pomanda has estimated its turnover at £1.3m with rapid growth in recent years.
Upgrade for unlimited company reports & a free credit check
Digital Therapeutics Ltd Health Check
Pomanda's financial health check has awarded Digital Therapeutics Ltd a 4 rating. We use a traffic light system to show it exceeds the industry average on 6 measures and has 3 areas for improvement. Company Health Check FAQs
6 Strong
3 Regular
3 Weak
Size
annual sales of £1.3m, make it larger than the average company (£835k)
- Digital Therapeutics Ltd
£835k - Industry AVG
Growth
3 year (CAGR) sales growth of 37%, show it is growing at a faster rate (6.4%)
- Digital Therapeutics Ltd
6.4% - Industry AVG
Production
with a gross margin of 34.2%, this company has a comparable cost of product (34.2%)
- Digital Therapeutics Ltd
34.2% - Industry AVG
Profitability
an operating margin of -387.6% make it less profitable than the average company (5.6%)
- Digital Therapeutics Ltd
5.6% - Industry AVG
Employees
with 30 employees, this is above the industry average (20)
30 - Digital Therapeutics Ltd
20 - Industry AVG
Pay Structure
on an average salary of £26.1k, the company has an equivalent pay structure (£26.1k)
- Digital Therapeutics Ltd
£26.1k - Industry AVG
Efficiency
resulting in sales per employee of £43.7k, this is equally as efficient (£49.2k)
- Digital Therapeutics Ltd
£49.2k - Industry AVG
Debtor Days
it gets paid by customers after 5 days, this is earlier than average (22 days)
- Digital Therapeutics Ltd
22 days - Industry AVG
Creditor Days
its suppliers are paid after 75 days, this is slower than average (16 days)
- Digital Therapeutics Ltd
16 days - Industry AVG
Stock Days
it holds stock equivalent to 8 days, this is less than average (13 days)
- Digital Therapeutics Ltd
13 days - Industry AVG
Cash Balance
has cash to cover current liabilities for 1 weeks, this is less cash available to meet short term requirements (103 weeks)
1 weeks - Digital Therapeutics Ltd
103 weeks - Industry AVG
Debt Level
it has a ratio of liabilities to total assets of 1756.1%, this is a higher level of debt than the average (26.3%)
1756.1% - Digital Therapeutics Ltd
26.3% - Industry AVG
DIGITAL THERAPEUTICS LTD financials
Digital Therapeutics Ltd's latest turnover from December 2023 is estimated at £1.3 million and the company has net assets of -£15.1 million. According to their latest financial statements, Digital Therapeutics Ltd has 30 employees and maintains cash reserves of £384.6 thousand as reported in the balance sheet.
Data source: Companies House, Pomanda Estimates
| Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Nov 2019 | Nov 2018 | Nov 2017 | Nov 2016 | |
|---|---|---|---|---|---|---|---|---|
| Turnover | ||||||||
| Other Income Or Grants | ||||||||
| Cost Of Sales | ||||||||
| Gross Profit | ||||||||
| Admin Expenses | ||||||||
| Operating Profit | ||||||||
| Interest Payable | ||||||||
| Interest Receivable | ||||||||
| Pre-Tax Profit | ||||||||
| Tax | ||||||||
| Profit After Tax | ||||||||
| Dividends Paid | ||||||||
| Retained Profit | ||||||||
| Employee Costs | ||||||||
| Number Of Employees | 30 | 44 | 26 | 13 | 9 | 8 | 3 | 2 |
| EBITDA* |
* Earnings Before Interest, Tax, Depreciation and Amortisation
| Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Nov 2019 | Nov 2018 | Nov 2017 | Nov 2016 | |
|---|---|---|---|---|---|---|---|---|
| Tangible Assets | 84,151 | 106,245 | 66,080 | 50,620 | 11,567 | 9,908 | 3,746 | 819 |
| Intangible Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments & Other | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Debtors (Due After 1 year) | 73,622 | 70,392 | 25,783 | 25,783 | 0 | 0 | 0 | 0 |
| Total Fixed Assets | 157,773 | 176,637 | 91,863 | 76,403 | 11,567 | 9,908 | 3,746 | 819 |
| Stock & work in progress | 20,926 | 2,577 | 3,095 | 14,638 | 0 | 0 | 0 | 0 |
| Trade Debtors | 18,253 | 65,398 | 6,273 | 6,094 | 12,774 | 264,883 | 8,390 | 11,905 |
| Group Debtors | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Misc Debtors | 332,000 | 525,066 | 855,000 | 523,717 | 206,148 | 0 | 0 | 0 |
| Cash | 384,611 | 740,030 | 1,949,291 | 244,639 | 138,704 | 0 | 304,481 | 0 |
| misc current assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| total current assets | 755,790 | 1,333,071 | 2,813,659 | 789,088 | 357,626 | 264,883 | 312,871 | 11,905 |
| total assets | 913,563 | 1,509,708 | 2,905,522 | 865,491 | 369,193 | 274,791 | 316,617 | 12,724 |
| Bank overdraft | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 4 |
| Bank loan | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Trade Creditors | 178,941 | 122,026 | 113,672 | 61,923 | 4,277 | 577,649 | 0 | 17,430 |
| Group/Directors Accounts | 15,633,488 | 11,495,090 | 6,714,945 | 2,591,422 | 0 | 0 | 0 | 0 |
| other short term finances | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| hp & lease commitments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| other current liabilities | 230,921 | 272,761 | 171,652 | 42,553 | 1,077,995 | 0 | 36,172 | 54,826 |
| total current liabilities | 16,043,350 | 11,889,877 | 7,000,269 | 2,695,898 | 1,082,272 | 577,649 | 36,172 | 72,260 |
| loans | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| hp & lease commitments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accruals and Deferred Income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| other liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| provisions | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| total long term liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| total liabilities | 16,043,350 | 11,889,877 | 7,000,269 | 2,695,898 | 1,082,272 | 577,649 | 36,172 | 72,260 |
| net assets | -15,129,787 | -10,380,169 | -4,094,747 | -1,830,407 | -713,079 | -302,858 | 280,445 | -59,536 |
| total shareholders funds | -15,129,787 | -10,380,169 | -4,094,747 | -1,830,407 | -713,079 | -302,858 | 280,445 | -59,536 |
| Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Nov 2019 | Nov 2018 | Nov 2017 | Nov 2016 | |
|---|---|---|---|---|---|---|---|---|
| Operating Activities | ||||||||
| Operating Profit | ||||||||
| Depreciation | 31,797 | 27,756 | 14 | |||||
| Amortisation | 0 | 0 | 0 | 0 | 0 | |||
| Tax | ||||||||
| Stock | 18,349 | -518 | -11,543 | 14,638 | 0 | 0 | 0 | 0 |
| Debtors | -236,981 | -226,200 | 331,462 | 336,672 | -45,961 | 256,493 | -3,515 | 11,905 |
| Creditors | 56,915 | 8,354 | 51,749 | 57,646 | -573,372 | 577,649 | -17,430 | 17,430 |
| Accruals and Deferred Income | -41,840 | 101,109 | 129,099 | -1,035,442 | 1,077,995 | -36,172 | -18,654 | 54,826 |
| Deferred Taxes & Provisions | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cash flow from operations | ||||||||
| Investing Activities | ||||||||
| capital expenditure | ||||||||
| Change in Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| cash flow from investments | ||||||||
| Financing Activities | ||||||||
| Bank loans | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Group/Directors Accounts | 4,138,398 | 4,780,145 | 4,123,523 | 2,591,422 | 0 | 0 | 0 | 0 |
| Other Short Term Loans | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Long term loans | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Hire Purchase and Lease Commitments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| other long term liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| share issue | ||||||||
| interest | ||||||||
| cash flow from financing | ||||||||
| cash and cash equivalents | ||||||||
| cash | -355,419 | -1,209,261 | 1,704,652 | 105,935 | 138,704 | -304,481 | 304,481 | 0 |
| overdraft | 0 | 0 | 0 | 0 | 0 | 0 | -4 | 4 |
| change in cash | -355,419 | -1,209,261 | 1,704,652 | 105,935 | 138,704 | -304,481 | 304,485 | -4 |
digital therapeutics ltd Credit Report and Business Information
Digital Therapeutics Ltd Competitor Analysis
Perform a competitor analysis for digital therapeutics ltd by selecting its closest rivals, whether from the HUMAN HEALTH AND SOCIAL WORK ACTIVITIES sector, other small companies, companies in WC1X area or any other competitors across 12 key performance metrics.
digital therapeutics ltd Ownership
DIGITAL THERAPEUTICS LTD group structure
Digital Therapeutics Ltd has no subsidiary companies.
Ultimate parent company
DIGITAL THERAPEUTICS LTD
09851330
digital therapeutics ltd directors
Digital Therapeutics Ltd currently has 4 directors. The longest serving directors include Mr Yusuf Sherwani (Nov 2015) and Mr Sarim Siddiqui (Nov 2015).
| officer | country | age | start | end | role |
|---|---|---|---|---|---|
| Mr Yusuf Sherwani | United Kingdom | 32 years | Nov 2015 | - | Director |
| Mr Sarim Siddiqui | England | 31 years | Nov 2015 | - | Director |
| Mr Maroof Ahmed | England | 31 years | Nov 2015 | - | Director |
| Mr Yusuf Sherwani | England | 32 years | Nov 2015 | - | Director |
P&L
December 2023turnover
1.3m
-20%
operating profit
-5.1m
0%
gross margin
34.2%
-2.53%
turnover
Turnover, or revenue, is the amount of sales generated by a company within the financial year.
Balance Sheet
December 2023net assets
-15.1m
+0.46%
total assets
913.6k
-0.39%
cash
384.6k
-0.48%
net assets
Total assets minus all liabilities
Similar Companies
digital therapeutics ltd company details
company number
09851330
Type
Private limited with Share Capital
industry
86900 - Other human health activities
incorporation date
November 2015
age
9
incorporated
UK
ultimate parent company
accounts
Small Company
last accounts submitted
December 2023
previous names
N/A
accountant
DONALD REID LIMITED
auditor
-
address
ps.03, third floor, peer house, ps.03, third floor, peer house, holborn, london, WC1X 8LZ
Bank
-
Legal Advisor
-
digital therapeutics ltd Charges & Mortgages
A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.
We found 1 charges/mortgages relating to digital therapeutics ltd. Currently there are 1 open charges and 0 have been satisfied in the past.
digital therapeutics ltd Companies House Filings - See Documents
| date | description | view/download |
|---|
